A child is examined by a doctor

Board & management

We have a highly experienced Board and Senior Executive Team. The Board sets the Company’s strategy and policies, and monitors progress towards meeting our objectives. This includes regular reviews of financial performance and critical business issues. The Senior Executive Team, led by Chief Executive Officer David Brennan, focuses on the day-to-day running of our business operations and our Company development, regularly reviewing and deciding all major business issues.

Senior Executive Team

The Board

  • Louis Schweitzer
    Louis Schweitzer
    Non-Executive Chairman Chairman of the Nomination and Governance Committee, member of the Remuneration Committee

    Appointed 11 March 2004

  • David Brennan
    David Brennan
    Executive Director Chief Executive Officer

    Appointed 14 March 2005

  • Simon Lowth
    Simon Lowth
    Executive Director Chief Financial Officer

    Appointed 5 November 2007

  • Marcus Wallenberg
    Marcus Wallenberg
    Non-Executive Director Member of the Science Committee

    Appointed 6 April 1999

  • Dame Nancy Rothwell
    Dame Nancy Rothwell
    Non-Executive Director Chairman of the Science Committee, member of the Remuneration Committee, member of the Nomination and Governance Committee

    Appointed 27 April 2006

  • John Varley
    John Varley
    Non-Executive Director Chairman of the Remuneration Committee, member of the Nomination and Governance Committee

    Appointed 26 July 2006

  • Michele Hooper
    Michele Hooper
    Senior Non-Executive Director Member of the Audit Committee, member of the Nomination and Governance Committee

    Appointed 1 July 2003

  • Jean-Philippe Courtois
    Jean-Philippe Courtois
    Non-Executive Director Member of the Audit Committee

    Appointed 18 February 2008

  • Rudy Markham
    Rudy Markham
    Non-Executive Director Member of the Audit Committee

    Appointed 12 September 2008

  • Bruce Burlington
    Bruce Burlington
    Non-Executive Director Member of the Science Committee, member of the Audit Committee

    Appointed 1 August 2010

  • Baroness Shriti Vadera
    Baroness Shriti Vadera
    Non-Executive Director and member of the Audit Committee

    Appointed 1 January 2011

Board Committee remits

The remits for AstraZeneca's Board Committees are available to view/download here:

 Non-communicable diseases are a global problem which account for some 36 million deaths every year

The increasing burden of NCDs in low and middle-income countries poses an economic, social and moral stumbling block to global health and prosperity. This underscores the importance of partnership to understand what the most significant problems are and to work together to solve them.

David Brennan

IFPMA President, AstraZeneca Chief Executive Officer

Bookmark & Share